Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors

By  

Current Diabetes Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of Type 2 Diabetes Mellitus: An Update

By  

Current Diabetes Reviews, Vol. 7, Iss. 6, 2011-11 ,pp. : 392-405

Bentham Science Publishers

Access to resources Recommend Favorite

Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes

By Fierabracci Vanna   Tata Vincenzo   Pocai Alessandro   Novelli Michela   Barberà Albert   Masiello Pellegrino  

Endocrine Journal, Vol. 19, Iss. 2, 2002-11 ,pp. : 177-184

Humana Press, Inc

Access to resources Recommend Favorite

Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review

By  

Current Vascular Pharmacology, Vol. 11, Iss. 6, 2013-11 ,pp. : 992-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Is There a Role for Oral Antihyperglycemics in Gestational Diabetes and Type 2 Diabetes during Pregnancy?

By Homko Carol J.   Sivan Eyal  

Treatments in Endocrinology, Vol. 3, Iss. 3, 2004-01 ,pp. : 133-139

Adis International

Access to resources Recommend Favorite